Addressing cholera with an 'integrated approach' in 2013

NewsGuard 100/100 Score

"There has been so much news related to cholera and cholera research since the start of 2013 I can only hope it means this year will be a banner year for prevention efforts," Helen Matzger, a program officer in new vaccine delivery at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog. She summarizes several recent articles covering cholera and asks, "How do we as a concerned community about this disease come together to work on an integrated approach to cholera control ... ? Where are the billions of dollars in funding? Perhaps most importantly, how does the cholera community work to increase the international and national level political will to work on a disease that almost solely affects the poorest of the poor?" Matzger continues, "These are hard questions and ones that I think about often. There are, however, hopeful signs that cholera is something a lot of other people are thinking more often about too. And we can all hope this collective thinking will lead to true action that benefits those at risk for cholera." She summarizes several initiatives working to fight cholera (1/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nigeria first to rollout new Men5CV vaccine against meningitis